Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Montali

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Scientific Reports|March 1, 2018
Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing StrategyAlessia Di Costanzo, Francesca Belardinilli, Diego Bailetti, et al.
Journal of Clinical Lipidology|December 2, 2025
Long-term efficacy and safety of lomitapide in patients with familial chylomicronemia syndrome: Data from an expanded access programAntonina Giammanco, Laura D'Erasmo, Gabriella Iannuzzo, et al.
Atherosclerosis|September 24, 2022
Efficacy and safety of lomitapide in familial chylomicronaemia syndromeAngelo B Cefalù, Laura D'Erasmo, Gabriella Iannuzzo, et al.
Atherosclerosis|December 29, 2016
Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storageAlessia Di Costanzo, Laura D'Erasmo, Licia Polimeni, et al.
JAMA|May 13, 2004
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and strokeFrancesco Cipollone, Elena Toniato, Stefano Martinotti, et al.
JHEP Reports : Innovation in Hepatology|February 18, 2026
Transcriptional and functional HBV-specific CD8 T cell changes from disease to functional cure in HBeAg-negative chronic hepatitis BMarzia Rossi, Andrea Vecchi, Camilla Tiezzi, et al.
Circulation|September 15, 2023
ANGPTL3 Deficiency and Risk of Hepatic SteatosisLaura D'Erasmo, Michele Di Martino, Thomas Neufeld, et al.
Journal of Hepatology|June 6, 2026
Dysregulated transcription in core- and pol-specific CD8 T cells can be targeted by HDAC inhibition to improve T-cell function in chronic hepatitis BCamilla Ceccatelli Berti, Ilaria Montali, Sara Doselli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 5, 2005
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian familiesLaura Calabresi, Livia Pisciotta, Anna Costantin, et al.
Nature Communications|September 18, 2024
Germline variant affecting p53β isoforms predisposes to familial cancerStephanie A Schubert, Dina Ruano, Sebastien M Joruiz, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Scientific Reports|March 1, 2018
Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing StrategyAlessia Di Costanzo, Francesca Belardinilli, Diego Bailetti, et al.
Journal of Clinical Lipidology|December 2, 2025
Long-term efficacy and safety of lomitapide in patients with familial chylomicronemia syndrome: Data from an expanded access programAntonina Giammanco, Laura D'Erasmo, Gabriella Iannuzzo, et al.
Atherosclerosis|September 24, 2022
Efficacy and safety of lomitapide in familial chylomicronaemia syndromeAngelo B Cefalù, Laura D'Erasmo, Gabriella Iannuzzo, et al.
Atherosclerosis|December 29, 2016
Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storageAlessia Di Costanzo, Laura D'Erasmo, Licia Polimeni, et al.
JAMA|May 13, 2004
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and strokeFrancesco Cipollone, Elena Toniato, Stefano Martinotti, et al.
JHEP Reports : Innovation in Hepatology|February 18, 2026
Transcriptional and functional HBV-specific CD8 T cell changes from disease to functional cure in HBeAg-negative chronic hepatitis BMarzia Rossi, Andrea Vecchi, Camilla Tiezzi, et al.
Circulation|September 15, 2023
ANGPTL3 Deficiency and Risk of Hepatic SteatosisLaura D'Erasmo, Michele Di Martino, Thomas Neufeld, et al.
Journal of Hepatology|June 6, 2026
Dysregulated transcription in core- and pol-specific CD8 T cells can be targeted by HDAC inhibition to improve T-cell function in chronic hepatitis BCamilla Ceccatelli Berti, Ilaria Montali, Sara Doselli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 5, 2005
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian familiesLaura Calabresi, Livia Pisciotta, Anna Costantin, et al.
Nature Communications|September 18, 2024
Germline variant affecting p53β isoforms predisposes to familial cancerStephanie A Schubert, Dina Ruano, Sebastien M Joruiz, et al.
Pageof 5